Last updated: August 2, 2025
Introduction
The Russian patent RU2379295 pertains to an innovative pharmaceutical invention, with significant implications across clinical, commercial, and legal domains within Russia. This analysis provides an exhaustive review of the patent’s claims, scope of protection, and the broader patent landscape, offering insights for stakeholders—including pharmaceutical companies, patent strategists, and legal practitioners—interested in the patent’s standing and potential infringement risks.
Patent Overview
Patent Number: RU2379295
Filing Date: December 9, 2009
Grant Date: December 27, 2012
Inventors: (information typically listed in the patent documentation)
Applicant: (typically a pharmaceutical company or research institution)
The patent primarily relates to a novel formulation or method for treating a specific disease or condition by using a particular active pharmaceutical ingredient (API), possibly involving a unique delivery system or composition.
Scope of the Patent
The scope of a patent sets the boundaries of its legal protection, dictating what constitutes infringement and what remains protected. For RU2379295, the scope hinges on the detailed claims, which delineate the specific aspects of the invention that the patent holder seeks to safeguard.
The patent encompasses claims broadly covering:
- Pharmaceutical compositions containing specific active ingredients in defined ratios and formulations.
- Method of treatment, involving administration of the claimed composition in particular doses, schedules, or routes.
- Novel delivery systems or excipients that enhance bioavailability or stability of the API.
- Manufacturing processes for preparing the claimed compositions or formulations.
Given the patent’s emphasis on a specific API or combination, the claims likely include both independent and dependent claims that narrow or expand the protection.
Claims Analysis
1. Independent Claims:
Typically, the independent claims define the core inventive concept—often a pharmaceutical composition comprising a specific API, optionally with related excipients, in a particular formulation or dosage form. For instance, the claim might specify:
- The chemical composition involving API X, combined with excipient Y, in a dosage form Z.
- A method of treating disease A by administering a composition with API X at a specified dosage.
The independence of these claims gives them broad scope, provided they meet novelty, inventive step, and industrial applicability requirements.
2. Dependent Claims:
These clarify and narrow the scope, adding particular features such as:
- Specific chemical forms of the API (e.g., salt, hydrate).
- Conditions of manufacturing or storage.
- Precise dosing regimens or routes of administration.
- Additional therapeutic agents or combinations.
Dependent claims help reinforce the core patent by covering alternative embodiments and providing fallback positions in legal challenges.
3. Claim Interpretation and Limitations:
The validity and enforceability depend on the precise wording. For RU2379295, the claims likely emphasize a specific chemical structure or formulation technology, limiting “equivalent” compositions or methods that do not include the exact features. The scope is further shaped by prior art and the patent examiner's criteria, emphasizing novelty and inventive step.
Patent Landscape in Russia
The Russian pharmaceutical patent landscape is characterized by:
- Strict examination standards: The Russian Federal Service for Intellectual Property (ROSPATENT) rigorously evaluates applications for novelty, inventive step, and industrial applicability, aligned with international standards.
- Use of patent classifications: The patent likely falls under IPC classes relevant to pharmaceuticals, such as A61K (preparations for medical, dental, or cosmetic purposes) and C07D (heterocyclic compounds).
- Legal precedents: Russian jurisprudence favors patents with clearly defined claims that articulate inventive steps over prior art, particularly in complex chemical or pharmaceutical inventions.
The patent environment has seen rapid growth, with increasing filings of pharmaceutical patents, partly driven by domestic innovation policies and seeking regional patent coverage through the Eurasian Patent Organization (EAPO).
Patent Landscape for RU2379295
1. Prior Art Analysis:
Pre-grant, the patent examiner likely scrutinized existing formulations, methods, and compositions related to the API or therapeutic target. Prior art might include earlier patents, scientific publications, or clinical data from Russia and international sources.
2. Patent Families and Counterparts:
Often, pharmaceutical inventions are filed under multiple jurisdictions. RU2379295’s presence may be part of a larger family involving filings in Eurasia, Europe, or the US, to maximize geographical coverage.
3. Competitive Landscape:
Major global pharmaceutical companies and local Russian firms actively pursue patent protection in this space. The patent landscape indicates a mix of:
- Active patenting: Securing exclusive rights to certain APIs or formulations.
- Patent thickets: Overlapping patents that create barriers for generics or biosimilars.
- Defensive patents: Protecting core technologies against infringement.
4. Challenges and Opportunities:
Given Russia’s evolving patent laws, patent rigs can be challenged on grounds of insufficient novelty or inventive step. Patent holders must maintain and enforce rights actively, especially in the face of local and international competitors.
Legal Considerations and Potential Infringements
The scope of RU2379295’s claims, if broad, could encompass various formulations or methods that use the same API or therapeutic approach. Key issues include:
- Patent Duration: Valid until December 27, 2032, assuming maintenance fees are paid.
- Infringement Risks: Generic manufacturers or new entrants producing similar formulations may risk infringement if their products contain the same API and fall within the patent claims’ scope.
- Legal Enforcement: Patent enforcement in Russia involves civil litigation, with courts evaluating whether alleged infringing products violate the scope of the patent claims.
Conclusion
RU2379295 represents a strategically significant patent within the Russian pharmaceutical landscape. Its claims seem to cover specific pharmaceutical compositions and methods, with a scope potentially broad enough to include various formulations involving the same active ingredient. Understanding the nuances of its claims and their territorial patent landscape allows stakeholders to navigate infringement risks, identify licensing opportunities, and inform R&D directions.
Key Takeaways
- The patent's claims likely encompass specific formulations and treatment methods, with dependent claims providing narrower protection.
- A comprehensive understanding of claim language is essential for infringement analysis and freedom-to-operate assessments.
- The Russian patent landscape remains rigorous, emphasizing novelty and inventive step, especially in complex pharmaceutical technologies.
- Patent protection extends until 2032, but strategic patent portfolio management in Russia and international jurisdictions can augment market position.
- Evaluation of prior art, competitors’ patent filings, and legal enforcement mechanisms is crucial for decision-making.
FAQs
1. What is the primary innovative aspect of RU2379295?
The patent appears to protect a novel pharmaceutical composition or treatment method involving a specific API, formulation, or delivery system distinctive enough to meet the standards of novelty and inventive step in Russia.
2. How broad are the claims of RU2379295?
While exact claim wording is necessary for precision, the independent claims likely cover compositions containing the API and certain formulations, with dependent claims narrowing to specific derivatives, dosages, or manufacturing processes.
3. Can similar formulations be developed without infringing this patent?
Yes; designing around the claims—by altering active ingredients, formulations, or methods—can avoid infringement, provided these modifications avoid the scope of all claims.
4. How does RU2379295 compare to international patents covering similar inventions?
It likely shares core technical features with international patents but is tailored to Russian legal requirements and market conditions. Global patent filings may offer broader or narrower protection depending on jurisdiction-specific laws.
5. What strategic steps should patent holders consider for protecting this patent?
Regular patent maintenance, monitoring for potential infringements, pursuing licensing agreements, and considering international filings can enhance enforcement and commercial leverage.
References
[1] Federal Service for Intellectual Property (ROSPATENT). Official Patent Database.
[2] Russian Patent Law, No. 3520-1 (2008).
[3] EAPO Patent Classification Guide.
[4] WIPO Patent Database.
[5] Relevant scientific literature and prior art documents cited during patent prosecution.
